Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptoms
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Objective The Framingham 10-risk of coronary heart disease (CHD) has been a widely studied estimate of cardiovascular risk in the general population. However, few studies have compared the relative risk of developing CHD in antipsychotic-treated patients with different psychiatric disorders, especially in older patients with psychotic symptoms. In this study, we compared the 10-year risk of developing CHD among middle-aged and older patients with psychotic symptoms to that in the general population. Method We analyzed baseline data from a study examining metabolic and cardiovascular effects of atypical antipsychotics in patients over age 40 with psychotic symptoms. After excluding patients with prior history of CHD and stroke, 179 subjects were included in this study. Among them, 68 had a diagnosis of schizophrenia, 42 mood disorder, 38 dementia, and 31 PTSD. Clinical evaluations included medical and pharmacologic treatment history, physical examination, and clinical labs for metabolic profiles. Using the Framingham 10–year risk of developing CHD based on the Framingham Heart Study (FHS), we calculated the risk CHD risk for each patient, and then compared relative risk in each psychiatric diagnosis to the risks reported in the FHS. Results The mean age of entire sample was 63 (range 40–94) years, 68% were men. The Framingham 10-year risk of CHD was increased by 79% in schizophrenia, 72% in PTSD, 61% in mood disorder with psychosis, and 11% in dementia relative to the risk in general population from the FHS. Conclusions In this sample of middle-aged and older patients with psychotic symptoms, we found a significantly increased 10-year risk of CHD relative to the estimated risk from FHS, with the greatest increased risk for patients with schizophrenia and PTSD. Development of optimally tailored prevention and intervention efforts to decrease different risk components in these patients could be an important step to help decrease the risks of CHD and overall mortality in this vulnerable population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
D'Agostino, R. B., Grundy, S., Sullivan, L. M., Wilson, P., & for the CHD Risk Prediction Group (2001) · JAMA · doi:10.1001/jama.286.2.180 · Cited by 2,108 · cited 1×
“The equation of the Framingham 10-year risk for CHD, derived from the Framingham Heart Study (FHS), has been validated andwidely used in different populations to predict the 10-year risk of CHD including angina, myocardial infarction, and cardiac death (Wilson et al, 1998; D'Agostino et al., 2001).”
Miller, M. D., Paradis, C. F., Houck, P. R., Mazumdar, S., Stack, J. A., Rifai, A. H., Mulsant, B., & Reynolds, C. F. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90005-n · Cited by 1,990 · cited 1×
“Physical comorbidity was evaluated with the Cumulative Illness Rating Scale for Geriatrics (CIRS-G); (Miller et al., 1992).”
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475 · cited 1×
“Patients with schizophrenia have been found to have higher rates of smoking, obesity, diabetes, and metabolic syndrome, which all contribute to the elevated risk of CHD (Isomaa et al, 2001; Alexander et al, 2003).”
Excess mortality of schizophrenia: A meta-analysis
Brown, S. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.6.502 · Cited by 869
Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., Lamberti, S., D'Agostino, R. B., Stroup, T. S., Davis, S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.010 · Cited by 528
Heppner, P. S., Crawford, E. F., Haji, U. A., Afari, N., Hauger, R. L., Dashevsky, B. A., Horn, P. S., Nunnink, S. E., & Baker, D. G. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-1 · Cited by 274
Daumit, G. L., Goff, D. C., Meyer, J. M., Davis, V. G., Nasrallah, H. A., McEvoy, J. P., Rosenheck, R., Davis, S. M., Hsiao, J. K., Stroup, T. S., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.006 · Cited by 223
Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study
Osby, U. (2000) · BMJ · doi:10.1136/bmj.321.7259.483 · Cited by 220
Cited by
Ringen, P. A., Engh, J. A., Birkenaes, A. B., Dieset, I., & Andreassen, O. A. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00137 · Cited by 339
Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia
Jeste, D. V., Wolkowitz, O. M., & Palmer, B. W. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr026 · Cited by 176
Self-citationLopez, O. L., Becker, J. T., Chang, Y.-F., Sweet, R. A., Aizenstein, H., Snitz, B., Saxton, J., McDade, E., Kamboh, M. I., DeKosky, S. T., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12081046 · Cited by 129
“In addition, studies in nonselected populations found an increase in heart disease and stroke among antipsychotic users (14, 15), and a similar trend has been noted in placebo-controlled studies (16).”
Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups
Joseph, J., Depp, C., Martin, A. S., Daly, R. E., Glorioso, D. K., Palmer, B. W., & Jeste, D. V. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.08.019 · Cited by 109
“For example, schizophrenia is associated with increased risk of higher bodymass index (BMI) (Lopresti and Drummond, 2013) and cardiovascular disease (Jin et al., 2011; Miller et al., 2015; Sicras-Mainar et al., y C-reactive protein levels in schizophrenia and comparison groups, 2013).”
Self-citation
Metadata
- Authors
- Jin, H., Folsom, D., Sasaki, A., Mudaliar, S., Henry, R., Torres, M., Golshan, S., Glorioso, D. K., & Jeste, D.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 125
- Issue
- 2-3
- Pages
- 295-299
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2055725451
- Cited by
- 55
- References
- 8
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptoms. https://app.cochat.ai/papers/10.1016/j.schres.2010.10.029
- The paper
- Jin, H., Folsom, D., Sasaki, A., Mudaliar, S., Henry, R., Torres, M., Golshan, S., Glorioso, D. K., & Jeste, D. (2011). Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptoms. Schizophrenia Research. https://doi.org/10.1016/j.schres.2010.10.029
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.